A second groundbreaking drug for Alzheimer's disease has been rejected for widespread use by the NHS in England; according to the drugs spending watchdog, the drug known as Donanemab does not offer sufficient value for money.
Recently awareness surrounding head injuries and concussions has grown significantly. This has raised concerns and questions about individuals and families.
Cambridge Vision Technology utilises AI-based technology to detect Alzheimer’s disease early on by using ocular biomarkers. They emphasise the importance of early detection of dementia to improve clinical outcomes for disease therapies and to maximise the economic and societal impact of this innovative new technology.
Pregnancy is not just a journey of physical transformation but also has deep changes in the brain, as revealed by groundbreaking research led by Professor Emily Jacobs' team at UC Santa Barbara.
Post-Traumatic Stress Disorder (PTSD) affects millions worldwide, but its impact often goes unrecognised. This condition can develop after experiencing or witnessing a life-threatening event, such as accidents, abuse, natural disasters or combat.
Researchers led by Maryam Shanechi at the USC Center for Neurotechnology have revealed an AI algorithm that could change the way we understand our brain activity and its applications in medical technology.
In a study led by Martin Luther University Halle-Wittenberg (MLU), researchers have uncovered intriguing insights into how our brains respond to different film genres.
Researchers from Yale University have uncovered a fundamental aspect of how the human brain wires itself during early development, long before sensory experiences influence...
Scientists at UC Davis Health have unveiled a cutting-edge brain-computer interface (BCI) that translates brain signals into speech with an astounding 97% accuracy.
Geoffrey Borg, the CEO of the International Mind Sports Association, offers a captivating insight into nurturing our future citizens through mind sports.
In June, Alzheimer's and brain awareness month, Mayo Clinic researchers have identified unique molecular signatures of blood-brain barrier dysfunction in Alzheimer's disease.
Scientists from Rice University and the University of Michigan have discovered that certain neurons in the brain not only replay past experiences during sleep but may also anticipate future events.
